Cargando…

Altered structural connectome in non-lesional newly diagnosed focal epilepsy: Relation to pharmacoresistance

Despite an expanding literature on brain alterations in patients with longstanding epilepsy, few neuroimaging studies investigate patients with newly diagnosed focal epilepsy (NDfE). Understanding brain network impairments at diagnosis is necessary to elucidate whether or not brain abnormalities are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kreilkamp, Barbara A.K., McKavanagh, Andrea, Alonazi, Batil, Bryant, Lorna, Das, Kumar, Wieshmann, Udo C., Marson, Anthony G., Taylor, Peter N., Keller, Simon S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841400/ https://www.ncbi.nlm.nih.gov/pubmed/33508622 http://dx.doi.org/10.1016/j.nicl.2021.102564

Ejemplares similares

Comparison of manual and automated fiber quantification tractography in patients with temporal lobe epilepsy
por: Kreilkamp, Barbara A.K., et al.
Publicado: (2019)

Fiber ball white matter modeling in focal epilepsy
por: Bryant, Lorna, et al.
Publicado: (2021)

Cortical stimulation in pharmacoresistant focal epilepsies
por: Ellrich, Jens
Publicado: (2020)

Resting‐state functional brain networks in adults with a new diagnosis of focal epilepsy
por: Alonazi, Batil K., et al.
Publicado: (2018)

Investigating imaging network markers of cognitive dysfunction and pharmacoresistance in newly diagnosed epilepsy: a protocol for an observational cohort study in the UK
por: de Bézenac, Christophe, et al.
Publicado: (2019)

7T MRI with post-processing for the presurgical evaluation of pharmacoresistant focal epilepsy
por: Chen, Cong, et al.
Publicado: (2021)

Connectomic profile and clinical phenotype in newly diagnosed glioma patients
por: Derks, Jolanda, et al.
Publicado: (2017)

Automated tractography in patients with temporal lobe epilepsy using TRActs Constrained by UnderLying Anatomy (TRACULA)
por: Kreilkamp, Barbara A.K., et al.
Publicado: (2017)

Genetic variations associated with pharmacoresistant epilepsy
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2020)

Radiological and Clinical Value of 7T MRI for Evaluating 3T-Visible Lesions in Pharmacoresistant Focal Epilepsies
por: Wang, Z. Irene, et al.
Publicado: (2021)

Vagal nerve stimulation for pharmacoresistant epilepsy in children
por: Hauptman, Jason S., et al.
Publicado: (2012)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)

Functional network topology in drug resistant and well-controlled idiopathic generalized epilepsy: a resting state functional MRI study
por: Pegg, Emily J, et al.
Publicado: (2021)

Glymphatic system function in patients with newly diagnosed focal epilepsy
por: Lee, Dong Ah, et al.
Publicado: (2022)

Cognitive Processing Impacts High Frequency Intracranial EEG Activity of Human Hippocampus in Patients With Pharmacoresistant Focal Epilepsy
por: Cimbalnik, Jan, et al.
Publicado: (2020)

Past Trauma Is Associated With a Higher Risk of Experiencing an Epileptic Seizure as Traumatic in Patients With Pharmacoresistant Focal Epilepsy
por: Mariotti, Sara, et al.
Publicado: (2021)

Evaluating whole‐brain tissue‐property changes in MRI‐negative pharmacoresistant focal epilepsies using MR fingerprinting
por: Su, Ting‐Yu, et al.
Publicado: (2022)

Pharmacoresistant Abdominal Seizures in Symptomatic Localization-Related Epilepsy
por: Tushar, Vadakke Puthanveetil, et al.
Publicado: (2021)

The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
por: Fattorusso, Antonella, et al.
Publicado: (2021)

Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?
por: Czornyj, Liliana, et al.
Publicado: (2021)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

The impact of epilepsy surgery on the structural connectome and its relation to outcome
por: Taylor, Peter N., et al.
Publicado: (2018)

Impact of diagnostic delay on seizure outcome in newly diagnosed focal epilepsy
por: Parviainen, Laura, et al.
Publicado: (2020)

Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy
por: Zhao, Fen, et al.
Publicado: (2023)

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
por: Grewal, Gurpreet Kaur, et al.
Publicado: (2017)

A complex systems view on the current hypotheses of epilepsy pharmacoresistance
por: Servilha‐Menezes, Gabriel, et al.
Publicado: (2022)

Efficacy and tolerability of eslicarbazepine acetate as monotherapy in patients of newly diagnosed focal epilepsy
por: Saxena, S., et al.
Publicado: (2021)

The white matter connectome as an individualized biomarker of language impairment in temporal lobe epilepsy
por: Kaestner, Erik, et al.
Publicado: (2019)

Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy
por: Yoon, Jung-Rim, et al.
Publicado: (2013)

‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy
por: Grote, Alexander, et al.
Publicado: (2022)

Limbic network co‐localization predicts pharmacoresistance in dysplasia‐related epilepsy
por: Cohen, Nathan T., et al.
Publicado: (2023)

Structural and effective connectivity in focal epilepsy
por: Parker, Christopher S., et al.
Publicado: (2017)

Multi-spectral diffusion MRI mega-analysis in genetic generalized epilepsy: Relation to outcomes
por: Kreilkamp, Barbara A.K., et al.
Publicado: (2023)

Different pharmacoresistance of focal epileptic spasms, generalized epileptic spasms, and generalized epileptic spasms combined with focal seizures
por: Takahashi, Yukitoshi, et al.
Publicado: (2021)

The dynamics of functional connectivity in neocortical focal epilepsy
por: Pedersen, Mangor, et al.
Publicado: (2017)

Effects of Surgical Side and Site on Mood and Behavior Outcome in Children with Pharmacoresistant Epilepsy
por: Andresen, Elizabeth N., et al.
Publicado: (2014)

Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
por: Contin, Manuela, et al.
Publicado: (2021)

Pharmacoresistant Epilepsy in Childhood: Think of the Cerebral Folate Deficiency, a Treatable Disease
por: Mafi, Sarah, et al.
Publicado: (2020)

Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy
por: El-Tallawy, Hamdy N, et al.
Publicado: (2021)

Network Substrates of Centromedian Nucleus Deep Brain Stimulation in Generalized Pharmacoresistant Epilepsy
por: Torres Diaz, Cristina V., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tr7hthjqrqg9rad457ks73rng8